Cargando…

Krill Oil Treatment Increases Distinct PUFAs and Oxylipins in Adipose Tissue and Liver and Attenuates Obesity-Associated Inflammation via Direct and Indirect Mechanisms

The development of obesity is characterized by the metabolic overload of tissues and subsequent organ inflammation. The health effects of krill oil (KrO) on obesity-associated inflammation remain largely elusive, because long-term treatments with KrO have not been performed to date. Therefore, we ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Gart, Eveline, Salic, Kanita, Morrison, Martine C., Caspers, Martien, van Duyvenvoorde, Wim, Heijnk, Marieke, Giera, Martin, Bobeldijk-Pastorova, Ivana, Keijer, Jaap, Storsve, Andreas B., Hals, Petter-Arnt, Kleemann, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401900/
https://www.ncbi.nlm.nih.gov/pubmed/34444996
http://dx.doi.org/10.3390/nu13082836
_version_ 1783745660234760192
author Gart, Eveline
Salic, Kanita
Morrison, Martine C.
Caspers, Martien
van Duyvenvoorde, Wim
Heijnk, Marieke
Giera, Martin
Bobeldijk-Pastorova, Ivana
Keijer, Jaap
Storsve, Andreas B.
Hals, Petter-Arnt
Kleemann, Robert
author_facet Gart, Eveline
Salic, Kanita
Morrison, Martine C.
Caspers, Martien
van Duyvenvoorde, Wim
Heijnk, Marieke
Giera, Martin
Bobeldijk-Pastorova, Ivana
Keijer, Jaap
Storsve, Andreas B.
Hals, Petter-Arnt
Kleemann, Robert
author_sort Gart, Eveline
collection PubMed
description The development of obesity is characterized by the metabolic overload of tissues and subsequent organ inflammation. The health effects of krill oil (KrO) on obesity-associated inflammation remain largely elusive, because long-term treatments with KrO have not been performed to date. Therefore, we examined the putative health effects of 28 weeks of 3% (w/w) KrO supplementation to an obesogenic diet (HFD) with fat derived mostly from lard. The HFD with KrO was compared to an HFD control group to evaluate the effects on fatty acid composition and associated inflammation in epididymal white adipose tissue (eWAT) and the liver during obesity development. KrO treatment increased the concentrations of EPA and DHA and associated oxylipins, including 18-HEPE, RvE(2) and 14-HDHA in eWAT and the liver. Simultaneously, KrO decreased arachidonic acid concentrations and arachidonic-acid-derived oxylipins (e.g., HETEs, PGD(2), PGE(2), PGF(2)α, TXB(2)). In eWAT, KrO activated regulators of adipogenesis (e.g., PPARγ, CEBPα, KLF15, STAT5A), induced a shift towards smaller adipocytes and increased the total adipocyte numbers indicative for hyperplasia. KrO reduced crown-like structures in eWAT, and suppressed HFD-stimulated inflammatory pathways including TNFα and CCL2/MCP-1 signaling. The observed eWAT changes were accompanied by reduced plasma leptin and increased plasma adiponectin levels over time, and improved insulin resistance (HOMA-IR). In the liver, KrO suppressed inflammatory signaling pathways, including those controlled by IL-1β and M-CSF, without affecting liver histology. Furthermore, KrO deactivated hepatic REL-A/p65-NF-κB signaling, consistent with increased PPARα protein expression and a trend towards an increase in IkBα. In conclusion, long-term KrO treatment increased several anti-inflammatory PUFAs and oxylipins in WAT and the liver. These changes were accompanied by beneficial effects on general metabolism and inflammatory tone at the tissue level. The stimulation of adipogenesis by KrO allows for safe fat storage and may, together with more direct PPAR-mediated anti-inflammatory mechanisms, attenuate inflammation.
format Online
Article
Text
id pubmed-8401900
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84019002021-08-29 Krill Oil Treatment Increases Distinct PUFAs and Oxylipins in Adipose Tissue and Liver and Attenuates Obesity-Associated Inflammation via Direct and Indirect Mechanisms Gart, Eveline Salic, Kanita Morrison, Martine C. Caspers, Martien van Duyvenvoorde, Wim Heijnk, Marieke Giera, Martin Bobeldijk-Pastorova, Ivana Keijer, Jaap Storsve, Andreas B. Hals, Petter-Arnt Kleemann, Robert Nutrients Article The development of obesity is characterized by the metabolic overload of tissues and subsequent organ inflammation. The health effects of krill oil (KrO) on obesity-associated inflammation remain largely elusive, because long-term treatments with KrO have not been performed to date. Therefore, we examined the putative health effects of 28 weeks of 3% (w/w) KrO supplementation to an obesogenic diet (HFD) with fat derived mostly from lard. The HFD with KrO was compared to an HFD control group to evaluate the effects on fatty acid composition and associated inflammation in epididymal white adipose tissue (eWAT) and the liver during obesity development. KrO treatment increased the concentrations of EPA and DHA and associated oxylipins, including 18-HEPE, RvE(2) and 14-HDHA in eWAT and the liver. Simultaneously, KrO decreased arachidonic acid concentrations and arachidonic-acid-derived oxylipins (e.g., HETEs, PGD(2), PGE(2), PGF(2)α, TXB(2)). In eWAT, KrO activated regulators of adipogenesis (e.g., PPARγ, CEBPα, KLF15, STAT5A), induced a shift towards smaller adipocytes and increased the total adipocyte numbers indicative for hyperplasia. KrO reduced crown-like structures in eWAT, and suppressed HFD-stimulated inflammatory pathways including TNFα and CCL2/MCP-1 signaling. The observed eWAT changes were accompanied by reduced plasma leptin and increased plasma adiponectin levels over time, and improved insulin resistance (HOMA-IR). In the liver, KrO suppressed inflammatory signaling pathways, including those controlled by IL-1β and M-CSF, without affecting liver histology. Furthermore, KrO deactivated hepatic REL-A/p65-NF-κB signaling, consistent with increased PPARα protein expression and a trend towards an increase in IkBα. In conclusion, long-term KrO treatment increased several anti-inflammatory PUFAs and oxylipins in WAT and the liver. These changes were accompanied by beneficial effects on general metabolism and inflammatory tone at the tissue level. The stimulation of adipogenesis by KrO allows for safe fat storage and may, together with more direct PPAR-mediated anti-inflammatory mechanisms, attenuate inflammation. MDPI 2021-08-18 /pmc/articles/PMC8401900/ /pubmed/34444996 http://dx.doi.org/10.3390/nu13082836 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gart, Eveline
Salic, Kanita
Morrison, Martine C.
Caspers, Martien
van Duyvenvoorde, Wim
Heijnk, Marieke
Giera, Martin
Bobeldijk-Pastorova, Ivana
Keijer, Jaap
Storsve, Andreas B.
Hals, Petter-Arnt
Kleemann, Robert
Krill Oil Treatment Increases Distinct PUFAs and Oxylipins in Adipose Tissue and Liver and Attenuates Obesity-Associated Inflammation via Direct and Indirect Mechanisms
title Krill Oil Treatment Increases Distinct PUFAs and Oxylipins in Adipose Tissue and Liver and Attenuates Obesity-Associated Inflammation via Direct and Indirect Mechanisms
title_full Krill Oil Treatment Increases Distinct PUFAs and Oxylipins in Adipose Tissue and Liver and Attenuates Obesity-Associated Inflammation via Direct and Indirect Mechanisms
title_fullStr Krill Oil Treatment Increases Distinct PUFAs and Oxylipins in Adipose Tissue and Liver and Attenuates Obesity-Associated Inflammation via Direct and Indirect Mechanisms
title_full_unstemmed Krill Oil Treatment Increases Distinct PUFAs and Oxylipins in Adipose Tissue and Liver and Attenuates Obesity-Associated Inflammation via Direct and Indirect Mechanisms
title_short Krill Oil Treatment Increases Distinct PUFAs and Oxylipins in Adipose Tissue and Liver and Attenuates Obesity-Associated Inflammation via Direct and Indirect Mechanisms
title_sort krill oil treatment increases distinct pufas and oxylipins in adipose tissue and liver and attenuates obesity-associated inflammation via direct and indirect mechanisms
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401900/
https://www.ncbi.nlm.nih.gov/pubmed/34444996
http://dx.doi.org/10.3390/nu13082836
work_keys_str_mv AT garteveline krilloiltreatmentincreasesdistinctpufasandoxylipinsinadiposetissueandliverandattenuatesobesityassociatedinflammationviadirectandindirectmechanisms
AT salickanita krilloiltreatmentincreasesdistinctpufasandoxylipinsinadiposetissueandliverandattenuatesobesityassociatedinflammationviadirectandindirectmechanisms
AT morrisonmartinec krilloiltreatmentincreasesdistinctpufasandoxylipinsinadiposetissueandliverandattenuatesobesityassociatedinflammationviadirectandindirectmechanisms
AT caspersmartien krilloiltreatmentincreasesdistinctpufasandoxylipinsinadiposetissueandliverandattenuatesobesityassociatedinflammationviadirectandindirectmechanisms
AT vanduyvenvoordewim krilloiltreatmentincreasesdistinctpufasandoxylipinsinadiposetissueandliverandattenuatesobesityassociatedinflammationviadirectandindirectmechanisms
AT heijnkmarieke krilloiltreatmentincreasesdistinctpufasandoxylipinsinadiposetissueandliverandattenuatesobesityassociatedinflammationviadirectandindirectmechanisms
AT gieramartin krilloiltreatmentincreasesdistinctpufasandoxylipinsinadiposetissueandliverandattenuatesobesityassociatedinflammationviadirectandindirectmechanisms
AT bobeldijkpastorovaivana krilloiltreatmentincreasesdistinctpufasandoxylipinsinadiposetissueandliverandattenuatesobesityassociatedinflammationviadirectandindirectmechanisms
AT keijerjaap krilloiltreatmentincreasesdistinctpufasandoxylipinsinadiposetissueandliverandattenuatesobesityassociatedinflammationviadirectandindirectmechanisms
AT storsveandreasb krilloiltreatmentincreasesdistinctpufasandoxylipinsinadiposetissueandliverandattenuatesobesityassociatedinflammationviadirectandindirectmechanisms
AT halspetterarnt krilloiltreatmentincreasesdistinctpufasandoxylipinsinadiposetissueandliverandattenuatesobesityassociatedinflammationviadirectandindirectmechanisms
AT kleemannrobert krilloiltreatmentincreasesdistinctpufasandoxylipinsinadiposetissueandliverandattenuatesobesityassociatedinflammationviadirectandindirectmechanisms